Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-04-05

Clinical Trial Update: A Phase III Efficacy Study of the Symptomatic Treatment of Seasonal Allergic Rhinitis With Bilastine [Phase 3]

View source ↗

Summary

This entry summarizes a Phase 3 trial evaluating bilastine for symptomatic treatment of seasonal allergic rhinitis, with study status listed as COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bilastine (bilastine)

Snippet

Sponsor: Faes Farma, S.A. | Conditions: Seasonal Allergic Rhinitis | Phase 3 | Status: COMPLETED